Rchr
J-GLOBAL ID：202001013320681767
Update date: May. 07, 2024
KAWAI HITOMI
KAWAI HITOMI
Affiliation and department：
Research theme for competitive and other funds (1)：
- 2021 - 2023 ヒト腫瘍組織を利用した、腫瘍の遠隔転移に関与する癌細胞ー基底膜接着因子の探索
Papers (15)：
-
Hitomi Kawai, Tamaki Miura, Natsumi Kawamatsu, Tomoki Nakagawa, Aya Ishii Shiba, Taichiro Yoshimoto, Yusuke Amano, Atsushi Kihara, Yuji Sakuma, Kazutaka Fujita, et al. Expression patterns of HNF4α, TTF-1, and SMARCA4 in lung adenocarcinomas: impacts on clinicopathological and genetic features. Virchows Archiv. 2024
-
Sayaka Arita, Tomofumi Nishino, Yuuki Mitani, Kotaro Sakashita, Sho Totsuka, Ryunosuke Watanabe, Hajime Mishima, Hitomi Kawai, Daisuke Matsubara, Yoshionao Oda, et al. Hemiarthroplasty for tumor-induced osteomalacia caused by tumor localized in femoral head: a case report. Journal of Surgical Case Reports. 2022. 2022. 10
-
Ryota Matsuoka, Hitomi Kawai, Takeshi Ito, Daisuke Matsubara. Determining Whether YAP1 and POU2F3 Are Antineuroendocrine Factors. Journal of Thoracic Oncology. 2022. 17. 9. 1070-1073
-
Masahiro Maki, Hong JeongMin, Tomoki Nakagawa, Hitomi Kawai, Noriaki Sakamoto, Yukio Sato, Masayuki Noguchi. Aberrant OCIAD2 demethylation in lung adenocarcinoma is associated with outcome. Pathology International. 2022. 72. 10. 496-505
-
Hitomi Kawai, Ryouta Matsuoka, Takeshi Ito, Daisuke Matsubara. Molecular Subtypes of High-Grade Neuroendocrine Carcinoma (HGNEC): What is YAP1-Positive HGNEC?. Frontiers in Bioscience-Landmark. 2022. 27. 3. 108-108
ｍore...
MISC (1)：
-
Shinji Iyama, Masao Ono, Hitomi Kawai-Nakahara, Ryan Husni, Tomoko Dai, Toshihiro Shiozawa, Akiko Sakata, Masayuki Noguchi. Drebrin: A New Targetable Molecular Marker of Lung Adenocarcinoma. JOURNAL OF THORACIC ONCOLOGY. 2017. 12. 1. S833-S834
Return to Previous Page
